Lexicon Pharmaceuticals
LXRX
LXRX
145 hedge funds and large institutions have $1.53B invested in Lexicon Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 50 increasing their positions, 38 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2% more funds holding
Funds holding: 142 → 145 (+3)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
23% less capital invested
Capital invested by funds: $2B → $1.53B (-$468M)
Holders
145
Holding in Top 10
2
Calls
$7.88M
Puts
$2.47M
Top Buyers
| 1 | +$15.7M | |
| 2 | +$7.04M | |
| 3 | +$5.64M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$3.23M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.34M |
Top Sellers
| 1 | -$17.1M | |
| 2 | -$9.27M | |
| 3 | -$8.01M | |
| 4 |
BM
Bridger Management
New York
|
-$6.09M |
| 5 |
Two Sigma Investments
New York
|
-$5.13M |